Conference Secretariat Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Tel: +1-888-843-8169, Fax: +1-650-618-1417, Ph: +1-650-268-9744, Toll free: +1-800-216-6499 [email protected] | [email protected]Tentative Program http://cancer-radiationoncology.conferenceseries.com/ conferenceseries.com eme: “Bridging the gap between Past, Current and Future Prospects of Cancer erapies” **For Available Speaker Slots** mailto:[email protected]Cancer Therapy & Radiation Oncology August 28-29, 2017 Brussels, Belgium 20 th Euro-Global Summit on
15.20‐17.00 5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
Awards & Closing Ceremony NOTE: Program Shedule is subject to change with final allotment of the speaker slots
Note: Workshops and Symposia slots are available. To book slot for Workshop and Symposium send us the proposal. Call for Abstract: http://cancer-radiationoncology.conferenceseries.com/call-for-abstracts.phpRegistration: http://cancer-radiationoncology.conferenceseries.com/registration.phpAbstract Submission: http://cancer-radiationoncology.conferenceseries.com/abstract-submission.phpPoster Competition: http://cancer-radiationoncology.conferenceseries.com/poster-competition.php
For more Details PS : http://cancer-radiationoncology.conferenceseries.com/
• You will be given about 5-7 minutes to present your poster including questions and answers. Judges may pose questions during the evaluation of the poster• Judges will even evaluate the student’s
enthusiasm towards their study, interest and knowledge in the area of their research
• The winners will be announced at the closing ceremony of the conference. The decision of the winner will be withdrawn if the winner/winners is/are not present at the time of announcement
• Apart from the judging time you may also be present at the poster to share your research with interested delegates
• Present your research through oral presentations • Learn about career development and the latest research
tools and technologies in your field • This forum will give pertinent and timely information
to those who conduct research and those who use and benefit from research
• Develop a foundation for collaboration among young researchers
• The forum will provide an opportunity for collegial interaction with other young investigators and established senior investigators across the globe
• Interact and share ideas with both peers and mentors
Special SessionsTitle: Advancing translation of Cancer Biomarkers to Dx applications: The opportunities, challenges and lessons learnedYiu-Lian Fong, Global Diagnostic Innovation Johnson & Johnson Innovation, UKTitle: Management of palatine fistula caused by granulocytic sarcomaRasha Aboelhassan, Nasser Institute Cancer Center, EgyptMajor Sessions: Cancer & Types | Cancer Imaging | Radiation Therapy | Head and Neck CancersBreast Cancer Chair: David Huang, Duke Kunshan University, ChinaChair: Mahmoud Abdelkader, German University, Egypt
Session IntroductionTitle: A new flexible endoscope for Transoral Robot Assisted Surgery (TORS) in head and neck lesionsStephan Lang, University Hospital Essen, GermanyTitle: Whole body MRI in the detection of skeletal metastasis: Our experience with 3 Tesla MRIAbdulkarim Jamal, George Eliot Hospital NHS Trust, UKTitle: Recent advances in radiotherapy treatment techniques David Huang, Duke Kunshan University, ChinaTitle: Diagnosis and management of pericardial mesothelioma Rasha Aboelhassan, Nasser Institute Cancer Center Egypt
Lunch Break @ Market PlaceTitle: Metavert for treating pancreatic cancerMouad Edderkaou, Cedars-Sinai Medical Center, USATitle: Experience and results of 42 patients after 177Lu-octreotate therapy in the Federal Capital of Brazil Gabriela El Haje Lobo, Núcleos Centro de Medicina Nuclear, BrazilTitle: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi ArabiaTitle: Gankyrin: A novel gene that promotes tamoxifen resistance in breast cancer patientsKhadijeh Jamialahmadi, Mashhad University of Medical Sciences, Iran Title: Metastatic papillary serous axillary lymph node from ovarian origin: A case reportMahdiss Mohamadianamiri, Shahid Beheshti University of Medical Sciences, Iran
Demonstration Session By ExibitorTitle: Demonstration on RIGVIR holdingAndrejs Repisevskis, RIGVIR holding, Latvia
Opening Ceremonyconferenceseries.com
Keynote SessionIntroductionTitle: Photodynamic therapy of cancer from bench to clinical application: Overview of 35 years experienceMohamed El-Far, Mansoura University, Egypt
Title: The effects of sustained delivery of Thymoquinone on SW 756 and E6E7 cervical cell linesHamed Benghuzzi , University of Mississippi Medical Center, USA
Title: Epigenetic silencing of promoter genes involved with head and neck carcinomas: Translational research to reverse epigenetic pathways in oncogenesis in head and neck cancer
M.A. Nezami, Pacific Medical Center of Hope, USA
Page 10
Title: Ambulatory chemotherapy fostering empowerment in cancer patients: An introduction and a feasibility study in LebanonRacha Sabbagh Dit Hawasli, Kingston University, UKTitle: Synergistic antitumor effects of radiation and proteasome inhibitor treatment in pancreatic cancer through the induction of autophagy and the down-regulation of TRAF6Ying-Jan Wang, National Cheng Kung University, Taiwan
Networking & Refreshment Break @ FoyerTitle: A propensity matched comparison of effects between video assisted thoracoscopic single-port, two-port and three-port pulmonary resection on lung cancerMu Ju-Wei, National Cancer Center, ChinaTitle: Throat and Lung cancers - Prevention and Management through (Exercise) Expectorant therapiesManikonda Prakash Rao, Osmania University, India
WorkshopTitle: Epigenetic therapies and the use of a Multi-Targeted Approach: A new concept in cancer therapeuticsM.A. Nezami, Pacific Medical Center of Hope, USA
Day 2 November 22, 2016Keynote Session
Title: To boost or not to boost in radiotherapy Bogusław Maciejewski, Cancer Center-Institute, Poland Title: Oncological applications of photodynamic diagnosis and therapyMahmoud Abdelkader, German University, EgyptTitle: Medical physics education and radiation medicineDavid Huang, Duke Kunshan University, China
Networking & Refreshment Break @ FoyerMajor Sessions: Anti- Cancer Therapy | Cancer Imaging | Radiation Therapy | Cancer Screening Session Chair: Nuri Unal, Akdeniz University, TurkeySession Co-Chair: Nina Tuncel, Akdeniz University, Turkey
Session IntroductionTitle: Cancer ImmunotherapySanjay R Jain, Morehouse School of Medicine, USATitle: Particle therapy: Past to futureNuri Unal, Akdeniz University, TurkeyTitle: Optic characteristics of anticancer drug NSC 631570 in urine samples sort healthy donors and prostate adenocarcinoma patients: Can it be exploited for the cancer diagnosticsLarysa M. Skivka, Taras Shevchenko National University, UkraineTitle: Physico-chemical properties of anticancer drug NSC631570Wassil Nowicky, Ukranian Anticancer Institute, AustriaTitle: Time factor and dose fractionation in radiotherapy for head and neck cancerBogusław Maciejewski , Cancer Center-Institute, Poland Title: Adaptive radiotherapy from past to futureNina Tuncel, Akdeniz University, TurkeyTitle: Neuroendocrine tumors treatment by radiolabeled somatostatin analogues (SA).Gabriela El Haje Lobo, Núcleos Centro de Medicina Nuclear, Brazil
Lunch Break @ Market Place
Poster Presentations Poster Presentations
P01Title: Direct medical cost associated with colorectal cancer in North of JordanQais Alefan, Jordan University of Science & Technology, Jordan
P02Title: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi Arabia
P03Title: A dosimetric comparison of the 3D-CRT planning of chest wall in post-mastectomy breast cancer patients, with and without breast board setup.Ambreen Muzaffar, Shifa International Hospital, Pakistan
Page 11
P04Title: Combinative drug therapy for cancer treatment: Exploring synergystic mode of action of Amino and Carboxy Terminal domain Inhibitors of Heat Shock Protein 90( HSP90)Bhaskar Kumar Chatterjee, Indian Institue of Technology, India
P05Title: Study of CYP3A4 and UGT1A1 polymorphisms in chronic myeloid leukemia patients administered nilotinib and relation to hyperbilirubinemiaShaimaa Ahamed Mohamed Ahamed Fahmy, Cairo University, Egypt
P06Title: Second malignant neoplasms after childhood cancer in Korea: A population-based cohort study (1993-2012)Eun-Kyeong Moon, National Cancer Center, South Korea
P07Title: Second primary cancer risk among kidney cancer patients in Korea: A population-based cohort study, 1993-2013 Jiwon Lim, National Cancer Center, South Korea
P08Title: Analysis of the association of apc, mlh1 and rassf1a genes Methylation with the risk of colorectal cancerZhunussova G, Institute of General Genetics and Cytology, Kazakhstan
P09Title: Prolactin pro-differentiation pathway in triple negative Breast Cancer: impact on Prognosis and potential therapyVanessa M. Lopez-Ozuna, McGill University, Canada
P10Title: In Vivo distribution evaluation of combination of lipo-dox and 188re-liposome in breast tumor modelWei-lin Lo, Institute of Nuclear Energy Research, Taiwan
P11Title: A new therapeutic targets of multiple myelomaDongqing Zhang, Shanghai jiao tong university, China
P12Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingLi Wang, Shanghai Jiaotong University, China
P13Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingYebin Xi, Shanghai Jiaotong University, China
P14Title: OVA66 increases ovarian cancer cell growth, invasion and survival via regulation of IGF-1R-MAPK signalingHailiang Ge, Shanghai Jiaotong University, China
P15Title: Efficacy of lithospermi radix water extracts for the attenuation of oxaliplatin-induced neurotoxicity. Jin-Mu Yi, Korea Institute of Oriental Medicine (KIOM), Republic of Korea
P16Title: KIOM-CRC 140(FFWE) attenuates oxaliplatin-induced neurotoxicity in vitro and vivo model.Jin-Mu Yi, Korea Institute of Oriental Medicine (KIOM), Republic of Korea
P17Title: Novel small molecule inhibitor of KPNB1 induce apoptosis and interfere with nuclear import in cancer cellsAderonke Ajayi-Smith, University of Cape Town Health Sciences Faculty, South Africa
P18Title: Synthesis, In Vitro antiproliferative activity and kinase inhibitory effects of new quinoline derivativesMohammed El-Gamal, University of Mansoura, Mansoura, Egypt.
P19Title: Intratumor stromal proportion confers aggressive phenotype of gastric signet ring cell carcinomasDakeun Lee, Ajou University, South Korea
P20Title: miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1Ling Zhang, Jilin University, China
Page 12
P21Title: Novel graphene oxide particles as a Plasmid-based Stat3 siRNA carrier for mouse hepatocarcinoma targeted therapyBaofeng Guo, Jilin University, China
P22Title: Prolactin receptor expression is an independent favorable prognostic marker in human breast cancerIbrahim Yaseen Hachim, McGill University, Canada
P23Title: The prognostic value of apoptotic marker (CD95) in adult acute leukemias Abdulwahab Abuderman, Salman bin Abdulaziz University, KSA
P24Title: mTOR pathway proteins expression after treatment of head and neck cancer cell lines with mTOR inhibitorsGabriel A Borges, University of Brasilia, Brazil
P25Title: A comprehensive analysis of malignancies diagnosed and treated in Andaman & Nicobar Island in one yearP P Abdul Shahid, Andaman and Nicobar Island, India
Special SessionTitle: Oncolytic virotherapy with Rigvir® Simona Donina, Riga Eastern Clinical University, LatviaMajor Sessions: Targeted Anti- Cancer Therapy | Cancer Biomarkers | Medical Image Processing Chair: Madhulika Singh, CSIR-Indian Institute of Toxicology Research, IndiCo- Chair: Ambreen Muzaffar, Shifa International Hospital, Pakistan
Title: Differential miRNAs expression profiles classify Mucin 1(+)/(-) human breast cancer stem cellsMadhulika Singh, CSIR-Indian Institute of Toxicology Research, IndiaTitle: Effects of histone deacetylase inhibitors on anti neo plastic activityJuhi Tiwari, Jayoti Vidyapeeth Women’s University, IndiaTitle: Investigating preoperative hematologic markers for the prognosis of ovarian cancer surgical outcomeMahdiss Mohamadianamiri, Shahid Beheshti University of Medical Sciences, Iran.
Networking & Refreshment BreakTitle: A dosimetric comparison of the 3D-CRT planning of chest wall in post-mastectomy breast cancer patients, with and without breast board setupAmbreen Muzaffar, Shifa International Hospital, PakistanTitle: Identifying the intra-tumoral heterogeneity of GBM using diffusion tensor image segmentation technique: A look inside application in prediction of overall survival Manijeh Beigi, Tehran University of Medical Sciences, IranTitle: Pyrexia of unknown originShrikant Solav, Spect Lab Nuclear Medicine Services, IndiaTitle: Up-regulation of the androgen receptor co-repressor; prohibitin, leads to cell cycle arrest in an androgen dependent prostate cancer cell line; LNCaPs. Sarah Koushyar, Cardiff University, UKTitle: Innovative approaches in metabolomics for understanding drug resistance in breast cancer Umber Saeed, Dow University of Health & Sciences (DUHS), Pakistan
Day 3 November 23, 2016Special Session
Title: Origins of life and role of quantum mechanics and thermodynamics approach in cancer Marek Roland, Digital Recordings, CanadaTitle: Biological interventions to interfere microenvironmental and endocrine machinery in cancer SubTitle: Application of endocrine manipulation in advanced cancerMA Nezami, Pacific Medical Center of Hope, USA
Networking & Refreshment Break
WorkshopTitle: Sequential targeted therapy in Cancer Applications and methods of treating actionable targets in multiphase approachMA Nezami, President Pacific Medical Center of Hope, USA
Page 13
Major Sessions: Cancer Cell Biology| Cancer Therapy| Cancer Biomarker | Hematology-oncology Chair: Wassil Nowicky, Ukranian Anticancer Institute, AustriaCo- Chair: Ying-Jan Wang, National Cheng Kung University, Taiwan
Session IntroductionTitle: Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicinThanos Mitrelias, University of Cambridge, UKTitle: Unusual presentations of posttransplant lymphoproliferative disorder in pediatric recipients of solid organ transplants: A systematic reviewNader Shakibazad, Shiraz University of Medical Sciences, IranTitle: Acute abdomen as an unusual presentation of acute myeloid leukemia: A case reportMehrpour Moradi, Shiraz University of Medical Sciences, IranTitle: D2 Gastrectomy: A single institution experienceAhmed Mohamed Osama Touny, Cairo University, Egypt Title: Psychosocial health status of patients diagnosed with chronic illnesses in Jordan. Dana Al Abeiat, SKSH, Shaikh khalifa Specialty Hospital, UAETitle: IGF-II and NSC-631570 compounds affect PMP22 gene expression in Pancreatic Ductal Adenocarcinoma. Could be the new target for both chemo-resistance and neuronal invasionNiccola Funel, University of Pisa, Italy
Lunch BreakTitle: Evaluation of the anticancer activities of the plant alkaloids Sanguinarine and Chelerythrine in human breast adenocarcinoma cellsIgor Vivian Almeida, State University of Maringa, Brazil Title: Vinca alkaloids induced peripheral neuropathy: Case series Shahbaz Ahmad Khan , Shaukat khanum Cancer hospital, Pakistan Title: In-vitro antioxidant and superoxide anion radical scavenging activity of pollen of Centella asiatica (Linn) Urban a traditional medicinal plant from Punjab-PakistanAnjum Perveen, University of Karachi, Pakistan
September 26-28, 2016 London, UK12th World Cancer Conference
Scientific Program
conferenceseries.com
Page 15
RegistrationsConcorde Suite 1&2
Day 1 September 26, 2016
Major Sessions: Cancer | Causes and Prevention | Cancer DiagnosisSession Chair: Alain Charest, Harvard Medical School, USASession Co-Chair: Olivier E Pardo, Imperial College London, UK
Session IntroductionTitle: The tumor supressor INPP4B functions as an oncogenic regulator in a subset of melanomasXu Dong Zhang, University of Newcastle, AustraliaTitle: Plasma thermograms-a new approach for cancer biomarker studiesNichola C Garbett, University of Louisville School of Medicine, USATitle: PDGFRα signaling strength confers sensitivity to vinblastine in glioblastomaAlain Charest, Harvard Medical School, USATitle: p53 protects tumor cell survival via a long non-coding RNA under glucose starvationMian Wu, University of Science & Technology of China, ChinaTitle: NRF2-mediated changes in glutathione metabolism mediate the resistance of EGFR-T790M mutant lung cancer cells to erlotinibOlivier E Pardo, Imperial College London, UK
Panel DiscussionGroup Photo
Lunch Break @ Aromi RestaurantMajor Sessions: Cancer Therapy | Cancer Drugs | Stem Cell ResearchSession Chair: Sabine Mai, University of Manitoba, CanadaSession Co-Chair: Shahid Gilani, University Hospital of North Midlands, UK
Session IntroductionTitle: A 3D imaging platform to determine the level of genomic instability in cancer Sabine Mai, University of Manitoba, Canada Title: Tumor imaging of small animal by phase contrast X-ray CT techniqueThet Thet Lwin, Kitasato University, JapanTitle: Circulating epithelial cells; ready for Routine?! Stefan Schuster, SIMFO GmbH Bayreuth, GermanyTitle: Severe colitis with docetaxel when used in combination with HER-2 receptor blocking antibodies in breast cancer patientsShahid Gilani, University Hospital of North Midlands, UKTitle: Lymhoepithelioma-like carcinoma of the uterine cervix– association with Epstein-Barr virus and Human papillomavirusAngel Danchev Yordanov, UMHAT Doctor Georgi Stranski-Pleven, BulgariaTitle: A prospective study of dose escalated image guided radiotherapy and concurrent chemotherapy for esophageal cancers: An evolving standard in developing country settingSrinivas Chilukuri, Yashoda Hospitals, India
Opening Ceremonyconferenceseries.com
Keynote Forum
Introduction
Title: The decline of the prevalence of cancers during organism senescenceAlvaro Macieira-Coelho, French Institute of Health and Medical Research(INSERM), FranceTitle: Early diagnosis of Ovarian carcinoma: Is it possible?Liane Deligdisch, Mount Sinai School of Medicine, USA
Title: Maintrac® CTC detection as a tool to uncover the strategies of tumor cells to evade eliminationKatharina Pachmann, SIMFO GmbH Bayreuth, Germany
Networking and Refreshment Break @ Concorde Foyer
Page 16
Networking and Refreshment Break @ Concorde FoyerTitle: Home based carers’ general knowledge of cancer in a rural village of south africaTakalani Grace Tshitangano, University of Venda, South AfricaTitle: Trends in the incidence of oral squamous cell carcinoma: A retrospective studyAmitha J Lewis, Manipal University, India
Panel DiscussionDay 2 September 27, 2016
Concorde Suite 2Keynote Forum
Introduction
Title: The role of stem-like glioma cells in GBM progression and post-treatment recurrenceElla L Kim, Johannes Gutenberg University Medical Centre, GermanyPerineural invasion in pancreatic cancerQingyong Ma, Xi’an Jiaotong University, China
Networking and Refreshment Break @ Concorde FoyerMajor Sessions: Organ Specific Cancers Session Chair: Javier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoSession Co-Chair: Ciro Roberto Rinaldi, University of Lincoln, UK
Session IntroductionTitle: Mechanism of Action of G-quadruplex forming oligonucleotide homologous to the telomere overhang in melanomaNeelu Puri, University of Illinois College of Medicine at Rockford, USATitle: PU.1 Expression correlates with patient disease status in the myelodysplatic syndromes, a new prognostic marker Ciro Roberto Rinaldi, University of Lincoln, UKTitle: The combination astemizole-gefitinib as a novel and promising therapy for human lung cancer: In vitro studiesJavier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoTitle: Near infrared transillumination detection of prostate carcinoma in vitroBesarion Partsvania, Georgian Technical University, GeorgiaTitle: Heightened state of oxidative stress in MCF-7 cells enhances growth potential and promotesEMT by increasing Akt and ERK activityMilad Bitar, Kuwait University, KuwaitTitle: Desmoplasia suppression by Metformin-mediated AMPK activation inhibits pancreatic cancer progressionQingyong Ma, Xi'an Jiaotong University, ChinaTitle: Cytocidal effects of active bufadienolides on human cancer cells and its possibility of enhancing host immunity as an adjuvant therapeutic reagentBo Yuan, Tokyo University of Pharmacy and Life Sciences, Japan
Lunch Break @ Aromi RestaurantYoung Researchers Forum
Title: Diet and colorectal cancer: Black raspberries prolong lifeStephanie May, Cardiff University, UKTitle: BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas & a mycotic aortic aneurysmDavid M Smith, St James’ University Hospital, UK Title: H3K4-specific histone methytranferase MLL3 regulates EMT in pancreatic cancer cellsChenyi Liu, University of Toronto, CanadaTitle: Prodigiosin associated anti metastatic effect and induction of apoptosis in adeno gastric carcinomaN Darshan, Central Food Technological Research Institute, IndiaTitle: frequent v600e & other non-hotspot braf mutations in adult differentiated thyroid cancer Murugan Avaniyapuram Kannan, King Faisal Specialist Hospital & Research Center, KSATitle: Association of proline allele at codon 72 of TP53 gene with triple negative breast cancer (TNBC) in females from North Eastern Region, IndiaKaustab Mukherjee, Regional Medical Research Centre-Dibrugarh, ICMR, India
Page 17
Title: Toxin-based targeted therapeutics for the treatment of solid tumorsStefania Zuppone, San Raffaele Scientific Institute, Italy
Major Sessions: Oncology and Cancer | Cancer Treatment and Therapeutics|Alternative Medicine and Cancer | Radiation OncologySession Chair: Jiri Vachtenheim, Charles University in Prague, Czech Republic
Session IntroductionTitle: GLI2, a Hedgehog signaling pathway effector, is a transcription activator of survivin expression in human tumor cellsJiri Vachtenheim, Charles University in Prague, Czech RepublicTitle: psiTPTE22-HERV functions as a tumor suppressor and is epigenetically down-regulated in gastric cancer Jessie Qiaoyi Liang, The Chinese University of Hong Kong, China
Networking and Refreshment Break @ Concorde FoyerTitle: Pathological diagnosis and workup of lung cancer in the middle east and north africa: patterns and challengesMohammed Al Hajjaj, University of Sharjah, UAETitle: Bamboo shoot consumption lowers the risk of breast cancer: A case-control study from North East Region, IndiaK Rekha Devi, Regional Medical Research Centre-Dibrugarh, ICMR, IndiaTitle: Anaemia in cancer patients undergoing radiotherapy: Our experience at the National Hospital Abuja, NigeriaChinedu S Aruah, National Hospital Abuja, NigeriaTitle: The anti-cancer effect of methanolic extract of Pistacia lentiscus MEPL in human ovarian cancer cellsImane Charid, University Abderrahmane Mira, AlgeriaTitle: Prosopis juliflora lleaves extract induces apoptosis in the breast cancer cells Raju N Gacche, Swami Ramanand Teerth Marathwada University, India
Session 1: Oncology & Organ Specific CancerSession Chair: Ajay Singh, Mitchell Cancer Institute, USA Session Co-Chair: Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, GermanyTitle: Understanding and overcoming chemoresistance of pancreatic cancerAjay Singh, Mitchell Cancer Institute, USATitle: Patent protection for diagnostics and therapeutics - The essentials and importance of second medical use patents in precision medicine Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, GermanyTitle: The chemopreventive potential of silver nanoparticles against UVB-induced skin carcinogenesisSeema Singh, Mitchell Cancer Institute, USAVP: Perioperative use of NSAID might prevent early relapses in breast and other cancers: An upstream approachMichael Retsky, Harvard TH Chan School of Public Health, USA
Group Photo 12:50-13:00Lunch Break @ Foyer
Title: Human borna disease virus infection impacts host proteome and histone lysine acetylation in human oligodendroglia cellsXia Liu, Institute of Forensic Science, ChinaTitle: Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabineYan-Shen Shan, Cheng Kung University, TaiwanTitle: Evaluation of actionable mutation (KRAS, BRAF and PIK3CA) in colon cancer: Determination of frequency, distribution pattern in Indian patientsB R Das, Research and Development, SRL Ltd., IndiaTitle: Challenges in treating Ca Nasopharynx, Ca Tonsil and post op Head neck cancers by Intensity Modulated RadiationtherapyAnitha Gopal, Fortis hospitals, India Title: One-step mixing with anti-tumor/anti-CD3 bispecific antibody enhances tumor targeting and therapeutic efficacy of ex vivo expanded T cellsKuo-Hsiang Chuang, Taipei Medical University, Taiwan
Networking & Refreshment Break @ FoyerTitle: Dendritic cell vaccine therapy in breast cancer patientsYathish Kumar, Karnataka cancer hopsital & research centre, IndiaTitle: Revisiting the value and role of anti-angiogenesis in solid tumors and the mechanism to inhibit angiogenesis, and their possible complications: Pediatric oncologists view. Mahdi Shahriari, Shiraz University of Medical Sciences, IranTitle: Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan Muhammad U Rashid, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan
Opening Ceremony conferenceseries.com
Keynote ForumIntroduction
Title: Sensitivity and specificity of the empirical Lymphocyte Genome Sensitivity (LGS) assay: Implications for improving cancer diagnostics Diana Anderson, University of Bradford, UKTitle: Optimizing HER2 assessment in breast cancer - Application of automated image analysisMartin Kristensson, Visiopharm, Denmark
Page 20
Day 2 July 12, 2016Amsterdam
Keynote ForumIntroduction
Title: Isolated Thoracic Perfusion with Chemofiltration (ITP-F) breaks through drug resistance in progressive and pretreated malignant pleural mesotheliomaKarl R Aigner, Medias Klinikum GmbH & Co KG, GermanyTitle: New method of quantitative, circulating tumor cell (CTC) diagnostic, treatment selection, monitoring and surveillance with superior outcome for the patientMatin Burrow, DMB-Diagnostics GmbH, Germany
Networking & Refreshment Break @ FoyerSession 2: Cancer Causes, Cancer Diagnostics, Cancer Treatment and Therapy & Clinical Oncology
Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Apollon Karseladze, N. Blokhin Cancer Research Center, Russian FederationTitle: General overview of the Comet assayDiana Anderson, University of Bradford, UKTitle: The march of pathologists into ‘Big Industry’ or the worries of a newly transformed surgical pathologistDiana Stanoeva, Histogenex, BelgiumTitle: Impairment of vascularization of the surface covering epithelium induces ischemia and promotes malignization: A new hypothesis of a possible mechanism of cancer pathogenesisApollon Karseladze, N. Blokhin Cancer Research Center, Russian FederationTitle: Cholesterol Import and steroidogenesis are Biosignatures for gastric cancer progressionWen-Lung Ma, China Medical University Hospital, Taiwan
Title: Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma Magalie Tardy, Centre Antoine Lacassagne, FranceTitle: The fetal risks from diagnostic use of radiation during pregnancy: A systematic review and proposal of a clinical protocol Mafalda Sofia Barros Gomes, Centro Hospitalar do Porto, PortugalTitle: Prognostic factors and their correlation with staging in patients with Multiple Myeloma: A single centre study in North IndiaTanvi Sood, Shri Ram Murti Smarak Institute of Medical Sciences, IndiaVP: MicroRNA-21 expression in primary breast cancer tissue among female patients and its correlation with chromosome 17 aneusomy Noura Ramadan, Suez Canal University, EgyptTitle: Combined bevacizumab and stereotactic radiosurgery for the treatment of a child with recurrent medulloblastomaMing Zhao, Chinese PLA General Hospital, China
Keynote ForumKeynote Presenation by Hirendra Nath BanerjeeElizabeth City State University, USA
Group PhotoNetworking & Refreshments Break @ Foyer
Track 1: Cancer Diagnostics MarketTrack 2: Cancer Diagnostics Types
Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: Fast Evaluation of Biopsy for Prostate Cancer Diagnosis by Fraunhofer IKTSAndreas Lehmann, Fraunhofer Institute for Ceramic Technologies and Systems IKTS, GermanyTitle: How to develop a cancer diagnostic device for the POC settingJuan Roman, Cambridge Consultants, UKTitle: Engineering design process and comparison of multi wavelength real time auto-fluorescence and fluorescence imaging guide system irradiance with xenon lamps and light-emitting diodes (LEDs) for open and laparoscopic cancer surgeryHyun Soo lim, Chungnam National University, South KoreaTitle: Development of female vaginal fluid collection device for the endometrial cancer preliminary studyJhih-Yan Cheng, National Tsing Hua University, Taiwan
Lunch Break @ RestaurantTrack 7: Predictive Cancer Biomarkers Track 9: Cancer Treatment
Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: The role of pancreatic stellate cells in pancreatic disordersOleg V Gerasimenko, Cardiff University, UKTitle: Differences of signalling pathways and miRNA expression in colon and breast carcinoma cell lines on hipoxic conditionHafize Seda Vatansever, Celal Bayar University, TurkeyTitle: The role of Epo/EpoR signaling pathway in colorectal cancerRenata Dobrila Dintinjana, Clinical Hospital Center Rijeka, CroatiaTitle:Fertility sparing surgery in early stages of cervical cancer Aleksandar Stefanović, President M.D. Ph. D UGOSCGRS, BelgradeTitle: Fertility sparing in young patients with early stages of endometrial cancer Katarina Jeremic, University of Belgrade School of Medicine, Serbia
Networking & Refreshments Break @ Foyer
Title: Anticancer activities of religiously important plants from IndiaRachana, Jaypee Institue of Information Technology, India
Olimpica-4
conferenceseries.com
Keynote Forum
Scientific Program
Introduction
Title: Sensitivity and Specificity of the Empirical Lymphocyte Genome Sensitivity (LGS) Assay: Implications for Improving Cancer DiagnosticsDiana Anderson, University of Bradford, UKTitle: Optimal Breast Cancer Pathology 2016Tibor Tot, Centarl Hospital Falun, Sweden
Page 23
Title: Prostatic tissue levels of chemical elements as cancer markersVladimir Zaichick, Medical Radiological Research Center, Russia
Special SessionTitle: Breast Cancer HeterogenityTibor Tot, Central Hospital Falun, Sweden Title: General Overview of the Comet assayDiana Anderson, University of Bradford, UK
Day 2 June 14, 2016Olimpica-4
Keynote Talk
Title: The UHRF1 expression in serum and tissue for gastric cancer detectionFeng Yan, Nanjing Medical University and Jiangsu Cancer Hospital, China
Track 3: Cancer Screening TestsTrack 6: Approaches in Cancer TherapyTrack 8: Cancer Genomics and EpigeneticsTrack 10: Recent Diagnostics Technologies
Session IntroductionSession Chair: Feng yan, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaSession Co-Chair: Senqing Chen, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaTitle: Serum biomarkers and ovarian cancer risk: Utility for early detection and preventionDayan Goodenowe, President, Phenomenome Discoveries Inc., CanadaTitle: Molecular basis of hereditary colorectal cancer and current research statusChen Senqing, Jiangsu Institute of Cancer Research, China
Networking & Refreshments Break @ FoyerTitle: The mechanisms of asparaginase-induced pancreatitisJulia V Gerasimenko, Cardiff University, UKTitle: Tumor-derived exosomes in cancer progression and treatment failureShaorong Yu, Jiangsu Institute of Cancer Research, ChinaTitle: Mast cells inhibition as therapeutic approach on mammary cancerAna I Faustino-Rocha, University of Trás-os-Montes and Alto Douro, Portugal
Poster PresentationsCDE001 Title: Prognostic significance of N-glycolyl GM3 ganglioside expression in non-small cell
lung carcinoma patients: New evidencesAdriana Carr Perez, Center of Molecular Immunology, Cuba
CDE002 Title: A functional approach for searching biomarkers of gliomaKopylov Alexey, Lomonosov Moscow State University, Russia
CDE003 Title: Molecular study of synthesis of protoporphyrin IX in fluoropositive and fluoronegative cell cultures of human glioblastomaPavlova Galina, Institute of Gene Biology-RAS, Russia
CDE004 Title: Renal cell carcinoma in kidney transplant candidatesKonstantinos A Zorbas, Temple University Hospital, USA
CDE005 Title: Frequent ID4 gene promoter hypermethylation in breast cancerYan Zhang, Jiangsu Cancer Hospital, China
CDE006 Title: Asymmetrical asymptomatic tonsilsJoseph Colclough, Northwick Park Hospital, UK
CDE007 Title: New ruthenium phthalocyanines in modulation of nitric oxide and singlet oxygen release: Physical chemical characterizations and improvement of cytotoxicity with liposomes against cancer cellsRamos L.C.B, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Brazil
CDE008 Title: The role of FABP9 in prostate cancerMajed Al Fayi, Liverpool University, UK
CDE009 Title: Experimental treatment of prostate cancer by suppressing the biological activity of FABP5Waseem Al-Jameel, University of Liverpool, UK
CDE010 Title: Improving Breast Cancer diagnosis by circulating microRNAs Julia Alejandra Pezuk, Instituto Sirio-Libanes de Ensino e Pesquisa – Hospital Sirio-Libanes- Sao Pablo, Brazil
Lunch Break @ RestaurantTitle: Comparison of the MRI sequences in ideal fiducial marker-based radiotherapy for prostate cancerOsamu Tanaka, Gifu Municipal Hospital, Japan
Page 24
Title: Monitoring cancer progression by detecting circulating cancer cells with both epithelial and mesenchymal featuresYong-Jie Lu, Queen Mary University of London, London, UKTitle: The status of medicinal plants and herbal drugs in prevention and treatment of cancerMajid Asadi-Samani, Shahrekord University of Medical Sciences, IranTitle: Probable non-papillomavirus etiology of warty carcinoma of the uterine cervixDimitrova B, Medical University Pleven, BulgariaTitle: The possible involvement of Epstein–Barr virus in the etiology of leukemia in Sudanese patientsHaitham Eltigani Mohammed Elawad, Omdurman Islamic University, Sudan
Networking & Refreshments Break @ FoyerTitle: Combination Therapy against NGcGM3 ganglioside and EGFR: A new approach for lung cancer treatment.Adriana Carr Perez, Center of Molecular Immunology,CubaTitle: Evaluation of the SYT-SSX2 fusion gene transcript in synovial sarcoma cells and microvesicles as a potential biomarker for synovial sarcomaFricke Alba, University of Freiburg, Germany
Panel DiscussionsAward & Closing Ceremony
Day 3 June 15, 2016Networking and Lunch @ Restaurant
![Synopsis: Special Issue on “Disruption of signaling ... · in 2018 on cancer research alone [3]. By comparison, Euro-pean cancer research funding in 2012–2013 amounted €7.6](https://static.documents.pub/doc/80x56/6025c9c7e0f511706b2ee0fb/synopsis-special-issue-on-aoedisruption-of-signaling-in-2018-on-cancer-research.jpg)
